Lethal and sublethal effects of five common herbicides on the wolf spider, Pardosa milvina (Araneae: Lycosidae).

We tested lethal and sublethal effects of five commonly applied herbicides on the agrobiont wolf spider Pardosa milvina. Pardosa were collected from two agricultural fields; one kept under continuous crop rotation and sprayed for over twenty years, the other had no pesticide application for the last twelve years. Male and female Pardosa from each site were exposed to one of seven herbicide treatments (atrazine, glyphosate, mesotrione, S-metolachlor, rimsulfuron, a combination of all five herbicides, or a distilled water control; N = 1201) and maintained for 52 days on the treated soil substrate. We recorded mortality, prey capture behavior, weight change, courtship behavior, and egg sac production across treatments. Mesotrione and the five-herbicide combination showed significantly higher mortality than control substrates while atrazine, glyphosate and S-metolachlor showed significantly higher survival than the control. Both male spiders and spiders collected from the conventional field had reduced survival under some herbicide treatments. Prey capture behavior varied significantly by herbicide treatment, sex, and site. We observed significant weight change differences in males and differences in egg sac production in females, with, compared to the control, significant male weight loss in the rimsulfuron treatment collected from the no herbicide field, and a decrease in egg sac production in rimsulfuron and S-metolachlor treatments among females collected from the no herbicide field. Our results show some herbicides may have modest but significant fitness benefits (atrazine, glyphosate, and S-metolachlor) while others strongly increase the mortality of a generalist predator (mesotrione and the combination herbicide treatment).

Cutaneous Lupus Erythematosus: Review and Considerations for Older Populations.

Though more common earlier in life, increasing attention is being focused on the development of cutaneous lupus erythematosus (CLE) in patients with advancing age. Studies show that CLE is more common in older populations than previously thought, and all CLE subtypes are possible in this group. Just like patients in the third or fourth decade of life, CLE may appear alongside or independent of systemic lupus erythematosus. Older populations manifesting CLE for the first time seem to have a lower risk of progression to systemic disease than younger peers, and are more commonly White. CLE must be carefully distinguished from other skin conditions that have a predilection for presentation in older populations, including rosacea, lichen planus, and other autoimmune conditions such as dermatomyositis or pemphigus/pemphigoid. It is thought that most CLE in older populations is drug-induced, with drug-induced subacute cutaneous lupus erythematosus being the most common subtype. Management of CLE in older patients focuses on eliminating unnecessary medications known to induce CLE, and otherwise treatment proceeds similarly to that in younger patients, with a few special considerations.

Cell Adhesion Molecules in Neuroblastoma: Complex Roles, Therapeutic Potential.

Neuroblastoma, a biologically heterogeneous tumor derived from neural crest cells, accounts for approximately 15% of childhood deaths from cancer. Recently, scientific literature has explored the role of cell adhesion molecules (CAMs) in cancer metastasis through cell detachment, migration, and invasion. Through a review of the current literature, it is evident that expression of different CAMs on neuroblastoma tumors is associated with favorable or unfavorable clinical prognosis. In patients diagnosed with neuroblastoma, treatment strategies include chemotherapy, surgery, radiotherapy, stem cell transplant, and more recently, immunotherapy and other targeted therapies. Long term survival remains poor despite multimodality treatment, especially for children with high-risk neuroblastoma, making it more necessary to explore innovative targeted therapies. CAMs have immense potential as therapeutic targets, but there is a need for growth and scientific exploration before CAM therapies become clinically useful.

The effectiveness of EGFR knockdown by RNAi lines varies depending on the tissue.

In Drosophila , the Epidermal growth factor receptor (EGFR) signaling pathway is known to be critically involved in multiple stages of development. We induced a loss of function phenotype in the eyes, wings, and somatic follicle cells using four EGFR RNAi lines: HMS05003 and JF02283, which produce short hairpin RNAs, as well as JF01368 and KK100051, which produce long hairpin RNAs. Using these four lines, we completed a systematic comparison of the ability of short hairpin vs long hairpin RNAi lines to produce loss-of-function phenotypes in the above-mentioned tissues. Tissue specific knockdown was achieved by using Gal4 drivers specific to the three tissues being studied. In the eyes and wings, the KK100051 line induced the most severe phenotype, while the JF01368 line was the least severe, but in the somatic follicle cells, the KK100051 line was the least effective, while the JF01368 and JF02283 lines were comparable with respect to phenotypic severity. We conclude that there is significant tissue specific variability exhibited by the different RNAi lines.